Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)

Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)

US Patent 9790279 · Granted Oct 17, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins composed of an interleukin-2 mutein and type I interferon2024
Antibodies with increased affinity for the epidermal growth factor receptor and 2023
Use of a CD6 binding partner and method based thereon2021
Methods for controlling fucosylation levels in proteins2019
Use of a CD6 binding partner and method based thereon2019
Methods for controlling fucosylation levels in proteins2018
TGFβ-derived polypeptides and uses thereof2017
IL-2 derivative polypeptides2015
Immunomodulatory interleukin-2 polypeptides and methods of treating melanoma2014
Method for the treatment of malignant and infectious chronic diseases2013
Pharmaceutical compositions capable of inducing apoptosis in tumour cells, usefu2013
Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactos2002